Pharmaceuticals

Global Antidiabetic Biguanides Market Insights, Forecast to 2025

  • QYR2790687
  • 111 Pages
  • October 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
In 2017, the global Antidiabetic Biguanides market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Antidiabetic Biguanides market based on company, product type, application and key regions.

This report studies the global market size of Antidiabetic Biguanides in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antidiabetic Biguanides in these regions.

This research report categorizes the global Antidiabetic Biguanides market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter\'s Five Forces Analysis.

The various contributors involved in the value chain of Antidiabetic Biguanides include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Antidiabetic Biguanides include

Pfizer

AstraZeneca

GlaxoSmithKline

Merck & Co

Eli Lilly

Sanofi

Takeda Pharmaceuticals

Novo Nordisk

Servier Laboratories

Boehringer Ingelheim

Bristol-Myers Squibb

Market Size Split by Type

Metformin IR

Metformin SR

Market Size Split by Application

Hospitals

Clinics

Other

Market size split by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

The study objectives of this report are:

To study and analyze the global Antidiabetic Biguanides market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Antidiabetic Biguanides market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Antidiabetic Biguanides manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Antidiabetic Biguanides with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Antidiabetic Biguanides submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antidiabetic Biguanides are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antidiabetic Biguanides market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Antidiabetic Biguanides Product

1.2 Key Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Antidiabetic Biguanides Market Size Growth Rate by Type

1.4.2 Metformin IR

1.4.3 Metformin SR

1.5 Market by Application

1.5.1 Global Antidiabetic Biguanides Market Size Growth Rate by Application

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Other

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Antidiabetic Biguanides Market Size

2.1.1 Global Antidiabetic Biguanides Revenue 2016-2025

2.1.2 Global Antidiabetic Biguanides Sales 2016-2025

2.2 Antidiabetic Biguanides Growth Rate by Regions

2.2.1 Global Antidiabetic Biguanides Sales by Regions

2.2.2 Global Antidiabetic Biguanides Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Antidiabetic Biguanides Sales by Manufacturers

3.1.1 Antidiabetic Biguanides Sales by Manufacturers

3.1.2 Antidiabetic Biguanides Sales Market Share by Manufacturers

3.1.3 Global Antidiabetic Biguanides Market Concentration Ratio (CR5 and HHI)

3.2 Antidiabetic Biguanides Revenue by Manufacturers

3.2.1 Antidiabetic Biguanides Revenue by Manufacturers (2016-2018)

3.2.2 Antidiabetic Biguanides Revenue Share by Manufacturers (2016-2018)

3.3 Antidiabetic Biguanides Price by Manufacturers

3.4 Antidiabetic Biguanides Manufacturing Base Distribution, Product Types

3.4.1 Antidiabetic Biguanides Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Antidiabetic Biguanides Product Category

3.4.3 Date of International Manufacturers Enter into Antidiabetic Biguanides Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

4.1 Global Antidiabetic Biguanides Sales by Type

4.2 Global Antidiabetic Biguanides Revenue by Type

4.3 Antidiabetic Biguanides Price by Type

5 Breakdown Data by Application

5.1 Overview

5.2 Global Antidiabetic Biguanides Breakdown Data by Application

6 North America

6.1 North America Antidiabetic Biguanides by Countries

6.1.1 North America Antidiabetic Biguanides Sales by Countries

6.1.2 North America Antidiabetic Biguanides Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Antidiabetic Biguanides by Type

6.3 North America Antidiabetic Biguanides by Application

6.4 North America Antidiabetic Biguanides by Company

7 Europe

7.1 Europe Antidiabetic Biguanides by Countries

7.1.1 Europe Antidiabetic Biguanides Sales by Countries

7.1.2 Europe Antidiabetic Biguanides Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Antidiabetic Biguanides by Type

7.3 Europe Antidiabetic Biguanides by Application

7.4 Europe Antidiabetic Biguanides by Company

8 Asia Pacific

8.1 Asia Pacific Antidiabetic Biguanides by Countries

8.1.1 Asia Pacific Antidiabetic Biguanides Sales by Countries

8.1.2 Asia Pacific Antidiabetic Biguanides Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Antidiabetic Biguanides by Type

8.3 Asia Pacific Antidiabetic Biguanides by Application

8.4 Asia Pacific Antidiabetic Biguanides by Company

9 Central & South America

9.1 Central & South America Antidiabetic Biguanides by Countries

9.1.1 Central & South America Antidiabetic Biguanides Sales by Countries

9.1.2 Central & South America Antidiabetic Biguanides Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Antidiabetic Biguanides by Type

9.3 Central & South America Antidiabetic Biguanides by Application

9.4 Central & South America Antidiabetic Biguanides by Company

10 Middle East and Africa

10.1 Middle East and Africa Antidiabetic Biguanides by Countries

10.1.1 Middle East and Africa Antidiabetic Biguanides Sales by Countries

10.1.2 Middle East and Africa Antidiabetic Biguanides Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Antidiabetic Biguanides by Type

10.3 Middle East and Africa Antidiabetic Biguanides by Application

10.4 Middle East and Africa Antidiabetic Biguanides by Company

11 Company Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Company Description

11.1.3 Sales, Revenue and Gross Margin of Antidiabetic Biguanides

11.1.4 Antidiabetic Biguanides Product Description

11.1.5 Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 Company Description

11.2.3 Sales, Revenue and Gross Margin of Antidiabetic Biguanides

11.2.4 Antidiabetic Biguanides Product Description

11.2.5 Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 Company Description

11.3.3 Sales, Revenue and Gross Margin of Antidiabetic Biguanides

11.3.4 Antidiabetic Biguanides Product Description

11.3.5 Recent Development

11.4 Merck & Co

11.4.1 Merck & Co Company Details

11.4.2 Company Description

11.4.3 Sales, Revenue and Gross Margin of Antidiabetic Biguanides

11.4.4 Antidiabetic Biguanides Product Description

11.4.5 Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Company Description

11.5.3 Sales, Revenue and Gross Margin of Antidiabetic Biguanides

11.5.4 Antidiabetic Biguanides Product Description

11.5.5 Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Company Description

11.6.3 Sales, Revenue and Gross Margin of Antidiabetic Biguanides

11.6.4 Antidiabetic Biguanides Product Description

11.6.5 Recent Development

11.7 Takeda Pharmaceuticals

11.7.1 Takeda Pharmaceuticals Company Details

11.7.2 Company Description

11.7.3 Sales, Revenue and Gross Margin of Antidiabetic Biguanides

11.7.4 Antidiabetic Biguanides Product Description

11.7.5 Recent Development

11.8 Novo Nordisk

11.8.1 Novo Nordisk Company Details

11.8.2 Company Description

11.8.3 Sales, Revenue and Gross Margin of Antidiabetic Biguanides

11.8.4 Antidiabetic Biguanides Product Description

11.8.5 Recent Development

11.9 Servier Laboratories

11.9.1 Servier Laboratories Company Details

11.9.2 Company Description

11.9.3 Sales, Revenue and Gross Margin of Antidiabetic Biguanides

11.9.4 Antidiabetic Biguanides Product Description

11.9.5 Recent Development

11.10 Boehringer Ingelheim

11.10.1 Boehringer Ingelheim Company Details

11.10.2 Company Description

11.10.3 Sales, Revenue and Gross Margin of Antidiabetic Biguanides

11.10.4 Antidiabetic Biguanides Product Description

11.10.5 Recent Development

11.11 Bristol-Myers Squibb

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

12.1 Market Opportunities and Drivers

12.2 Market Challenges

12.3 Market Risks/Restraints

12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis

13.1 Value Chain Analysis

13.1.1 Typical Suppliers of Key Antidiabetic Biguanides Raw Material

13.1.2 Antidiabetic Biguanides Customers

13.2 Sales Channels Analysis

13.2.1 Sales Channels Analysis

13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

15.3 Disclaimer

List of Tables and Figures

Figure Picture of Antidiabetic Biguanides

Figure Global Antidiabetic Biguanides Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025)

Figure Global Antidiabetic Biguanides Production Market Share by Types (Product Category) in 2017

Figure Metformin IR Product Picture

Table Major Manufacturers of Metformin IR

Figure Metformin SR Product Picture

Table Major Manufacturers of Metformin SR

Table Global Antidiabetic Biguanides Market Size Growth Rate by Application 2018-2025 (K Pcs)

Figure Hospitals

Figure Clinics

Figure Other

Figure Antidiabetic Biguanides Report Years Considered

Figure Global Antidiabetic Biguanides Market Size 2016-2025 (Million US$)

Figure Global Antidiabetic Biguanides Sales 2016-2025 (K Pcs)

Table Global Antidiabetic Biguanides Market Size by Regions 2016-2025 (K Pcs) & (Million US$)

Table Global Antidiabetic Biguanides Sales by Regions 2016-2025 (K Pcs)

Table Global Antidiabetic Biguanides Sales Market Share by Regions 2016-2025

Figure Global Antidiabetic Biguanides Sales Market Share by Regions 2016-2025

Figure 2017 Global Antidiabetic Biguanides Sales Market Share by Regions

Table Global Antidiabetic Biguanides Revenue by Regions 2016-2025 (Million US$)

Table Global Antidiabetic Biguanides Revenue Market Share by Regions 2016-2025

Figure Global Antidiabetic Biguanides Revenue Market Share by Regions 2016-2025

Figure 2017 Global Antidiabetic Biguanides Revenue Market Share by Regions

Table Global Antidiabetic Biguanides Sales by Manufacturers (2016-2018) (K Pcs)

Table Global Antidiabetic Biguanides Sales Share by Manufacturers (2016-2018)

Figure Global Antidiabetic Biguanides Sales Share by Manufacturers in 2017

Table Antidiabetic Biguanides Revenue by Manufacturers (2016-2018) (Million US$)

Table Antidiabetic Biguanides Revenue Share by Manufacturers (2016-2018)

Figure Antidiabetic Biguanides Value Share by Manufacturers in 2017

Table Global Antidiabetic Biguanides Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Manufacturers Antidiabetic Biguanides Price (2016-2018) (USD/Pcs)

Table Antidiabetic Biguanides Manufacturers Manufacturing Base Distribution and Headquarters

Table Manufacturers Antidiabetic Biguanides Product Category

Table Date of International Manufacturers Enter into Antidiabetic Biguanides Market

Table Manufacturers Mergers & Acquisitions, Expansion Plans

Table Global Antidiabetic Biguanides Sales by Type (2016-2025) (K Pcs)

Table Global Antidiabetic Biguanides Sales Share by Type (2016-2025)

Figure Global Antidiabetic Biguanides Sales Market Share by Type (2016-2025)

Figure Global Antidiabetic Biguanides Sales Market Share by Type in 2017

Table Global Antidiabetic Biguanides Revenue by Type (2016-2025) (Million US$)

Table Global Antidiabetic Biguanides Revenue Share by Type (2016-2025)

Figure Global Antidiabetic Biguanides Revenue Market Share by Type (2016-2025)

Figure Global Antidiabetic Biguanides Revenue Market Share by Type in 2017

Table Antidiabetic Biguanides Price by Type 2013-2018 (USD/Pcs)

Table Global Antidiabetic Biguanides Sales by Application (2016-2025) (K Pcs)

Table Global Antidiabetic Biguanides Sales Share by Application (2016-2025)

Figure Global Sales Antidiabetic Biguanides Market Share by Application (2016-2025)

Figure Global Sales Antidiabetic Biguanides Market Share by Application (2016-2025)

Figure North America Antidiabetic Biguanides Sales Growth Rate 2016-2025 (K Pcs)

Figure North America Antidiabetic Biguanides Revenue Growth Rate 2016-2025 (Million US$)

Table North America Antidiabetic Biguanides Sales by Countries (2016-2025) (K Pcs)

Table North America Antidiabetic Biguanides Sales Market Share by Countries (2016-2025)

Figure 2017 North America Antidiabetic Biguanides Sales Market Share by Countries

Table North America Antidiabetic Biguanides Revenue by Countries (2016-2025) (Million US$)

Table North America Antidiabetic Biguanides Revenue Market Share by Countries (2016-2025)

Figure 2017 North America Antidiabetic Biguanides Revenue Market Share by Countries

Figure United States Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure United States Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Canada Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Canada Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Mexico Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Mexico Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Table North America Antidiabetic Biguanides Sales by Type (2016-2025) (K Pcs)

Table North America Antidiabetic Biguanides Sales Market Share by Type (2016-2025)

Figure 2017 North America Antidiabetic Biguanides Market Share by Type

Table North America Antidiabetic Biguanides Sales by Application (2016-2025) (K Pcs)

Table North America Antidiabetic Biguanides Sales Market Share by Application (2016-2025)

Figure 2017 North America Antidiabetic Biguanides Market Share by Application

Table North America Antidiabetic Biguanides Sales by Company (2016-2018) (K Pcs)

Table North America Antidiabetic Biguanides Sales Market Share by Company (2016-2018)

Figure North America Antidiabetic Biguanides Sales Market Share by Company in 2017

Figure Europe Antidiabetic Biguanides Sales Growth Rate 2016-2025 (K Pcs)

Figure Europe Antidiabetic Biguanides Revenue Growth Rate 2016-2025 (Million US$)

Table Europe Antidiabetic Biguanides Sales by Countries (2016-2025) (K Pcs)

Table Europe Antidiabetic Biguanides Sales Market Share by Countries (2016-2025)

Figure 2017 Europe Antidiabetic Biguanides Sales Market Share by Countries

Table Europe Antidiabetic Biguanides Revenue by Countries (2016-2025) (Million US$)

Table Europe Antidiabetic Biguanides Revenue Market Share by Countries (2016-2025)

Figure 2017 Europe Antidiabetic Biguanides Revenue Market Share by Countries

Figure Germany Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Germany Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (K Pcs)

Figure France Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure France Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (K Pcs)

Figure UK Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure UK Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Italy Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Italy Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Russia Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Russia Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Table Europe Antidiabetic Biguanides Sales by Type (2016-2025) (K Pcs)

Table Europe Antidiabetic Biguanides Sales Market Share by Type (2016-2025)

Figure 2017 Europe Antidiabetic Biguanides Market Share by Type

Table Europe Antidiabetic Biguanides Sales by Application (2016-2025) (K Pcs)

Table Europe Antidiabetic Biguanides Sales Market Share by Application (2016-2025)

Figure 2017 Europe Antidiabetic Biguanides Market Share by Application

Table Europe Antidiabetic Biguanides Sales by Company (2016-2018) (K Pcs)

Table Europe Antidiabetic Biguanides Sales Market Share by Company (2016-2018)

Figure Europe Antidiabetic Biguanides Sales Market Share by Company in 2017

Figure Asia Pacific Antidiabetic Biguanides Sales Growth Rate 2016-2025 (K Pcs)

Figure Asia Pacific Antidiabetic Biguanides Revenue Growth Rate 2016-2025 (Million US$)

Table Asia Pacific Antidiabetic Biguanides Sales by Countries (2016-2025) (K Pcs)

Table Asia Pacific Antidiabetic Biguanides Sales Market Share by Countries (2016-2025)

Figure 2017 Asia Pacific Antidiabetic Biguanides Sales Market Share by Countries

Table Asia Pacific Antidiabetic Biguanides Revenue by Countries (2016-2025) (Million US$)

Table Asia Pacific Antidiabetic Biguanides Revenue Market Share by Countries (2016-2025)

Figure 2017 Asia Pacific Antidiabetic Biguanides Revenue Market Share by Countries

Figure China Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure China Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Japan Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Japan Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Korea Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Korea Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure India Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure India Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Australia Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Australia Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Indonesia Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Indonesia Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Malaysia Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Malaysia Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Philippines Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Philippines Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Thailand Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Thailand Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Vietnam Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Vietnam Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Singapore Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Singapore Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Table Asia Pacific Antidiabetic Biguanides Sales by Type (2016-2025) (K Pcs)

Table Asia Pacific Antidiabetic Biguanides Sales Market Share by Type (2016-2025)

Figure 2017 Asia Pacific Antidiabetic Biguanides Market Share by Type

Table Asia Pacific Antidiabetic Biguanides Sales by Application (2016-2025) (K Pcs)

Table Asia Pacific Antidiabetic Biguanides Sales Market Share by Application (2016-2025)

Figure 2017 Asia Pacific Antidiabetic Biguanides Market Share by Application

Table Asia Pacific Antidiabetic Biguanides Sales by Company (2016-2018) (K Pcs)

Table Asia Pacific Antidiabetic Biguanides Sales Market Share by Company (2016-2018)

Figure Asia Pacific Antidiabetic Biguanides Sales Market Share by Company in 2017

Figure Central & South America Antidiabetic Biguanides Sales Growth Rate 2016-2025 (K Pcs)

Figure Central & South America Antidiabetic Biguanides Revenue Growth Rate 2016-2025 (Million US$)

Table Central & South America Antidiabetic Biguanides Sales by Countries (2016-2025) (K Pcs)

Table Central & South America Antidiabetic Biguanides Sales Market Share by Countries (2016-2025)

Figure 2017 Central & South America Antidiabetic Biguanides Sales Market Share by Countries

Table Central & South America Antidiabetic Biguanides Revenue by Countries (2016-2025) (Million US$)

Table Central & South America Antidiabetic Biguanides Revenue Market Share by Countries (2016-2025)

Figure 2017 Central & South America Antidiabetic Biguanides Revenue Market Share by Countries

Figure Brazil Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Brazil Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Argentina Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Argentina Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Table Central & South America Antidiabetic Biguanides Sales by Type (2016-2025) (K Pcs)

Table Central & South America Antidiabetic Biguanides Sales Market Share by Type (2016-2025)

Figure 2017 Central & South America Antidiabetic Biguanides Market Share by Type

Table Central & South America Antidiabetic Biguanides Sales by Application (2016-2025) (K Pcs)

Table Central & South America Antidiabetic Biguanides Sales Market Share by Application (2016-2025)

Figure 2017 Central & South America Antidiabetic Biguanides Market Share by Application

Table Central & South America Antidiabetic Biguanides Sales by Company (2016-2018) (K Pcs)

Table Central & South America Antidiabetic Biguanides Sales Market Share by Company (2016-2018)

Figure Central & South America Antidiabetic Biguanides Sales Market Share by Company in 2017

Figure Middle East and Africa Antidiabetic Biguanides Sales Growth Rate 2016-2025 (K Pcs)

Figure Middle East and Africa Antidiabetic Biguanides Revenue Growth Rate 2016-2025 (Million US$)

Table Middle East and Africa Antidiabetic Biguanides Sales by Countries (2016-2025) (K Pcs)

Table Middle East and Africa Antidiabetic Biguanides Sales Market Share by Countries (2016-2025)

Figure 2017 Middle East and Africa Antidiabetic Biguanides Sales Market Share by Countries

Table Middle East and Africa Antidiabetic Biguanides Revenue by Countries (2016-2025) (Million US$)

Table Middle East and Africa Antidiabetic Biguanides Revenue Market Share by Countries (2016-2025)

Figure 2017 Middle East and Africa Antidiabetic Biguanides Revenue Market Share by Countries

Figure GCC Countries Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure GCC Countries Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Turkey Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Turkey Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure Egypt Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure Egypt Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Figure South Africa Antidiabetic Biguanides Sales Growth Rate (2016-2025) (K Pcs)

Figure South Africa Antidiabetic Biguanides Revenue Growth Rate (2016-2025) (Million US$)

Table Middle East and Africa Antidiabetic Biguanides Sales by Type (2016-2025) (K Pcs)

Table Middle East and Africa Antidiabetic Biguanides Sales Market Share by Type (2016-2025)

Figure 2017 Middle East and Africa Antidiabetic Biguanides Market Share by Type

Table Middle East and Africa Antidiabetic Biguanides Sales by Application (2016-2025) (K Pcs)

Table Middle East and Africa Antidiabetic Biguanides Sales Market Share by Application (2016-2025)

Figure 2017 Middle East and Africa Antidiabetic Biguanides Market Share by Application

Table Middle East and Africa Antidiabetic Biguanides Sales by Company (2016-2018) (K Pcs)

Table Middle East and Africa Antidiabetic Biguanides Sales Market Share by Company (2016-2018)

Figure Middle East and Africa Antidiabetic Biguanides Sales Market Share by Company in 2017

Table Pfizer Company Details

Table Pfizer Antidiabetic Biguanides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Pfizer Recent Development

Table AstraZeneca Company Details

Table AstraZeneca Antidiabetic Biguanides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table AstraZeneca Recent Development

Table GlaxoSmithKline Company Details

Table GlaxoSmithKline Antidiabetic Biguanides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table GlaxoSmithKline Recent Development

Table Merck & Co Company Details

Table Merck & Co Antidiabetic Biguanides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Merck & Co Recent Development

Table Eli Lilly Company Details

Table Eli Lilly Antidiabetic Biguanides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Eli Lilly Recent Development

Table Sanofi Company Details

Table Sanofi Antidiabetic Biguanides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Sanofi Recent Development

Table Takeda Pharmaceuticals Company Details

Table Takeda Pharmaceuticals Antidiabetic Biguanides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Takeda Pharmaceuticals Recent Development

Table Novo Nordisk Company Details

Table Novo Nordisk Antidiabetic Biguanides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Novo Nordisk Recent Development

Table Servier Laboratories Company Details

Table Servier Laboratories Antidiabetic Biguanides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Servier Laboratories Recent Development

Table Boehringer Ingelheim Company Details

Table Boehringer Ingelheim Antidiabetic Biguanides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018)

Table Boehringer Ingelheim Recent Development

Table Bristol-Myers Squibb Company Details

Figure GDP by Regions / Largest Economies Pie Chart in 2016

Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060

Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016

Figure Saving Rate Total, % of GDP, 2015

Table Antidiabetic Biguanides Value Chain

Table Typical Suppliers of Key Antidiabetic Biguanides Raw Material

Table Antidiabetic Biguanides Customers List

Table Antidiabetic Biguanides Sales Channels

Table Antidiabetic Biguanides Distributors List

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370